Atlas Trials

Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

Clinical trial NCT04853992 · COMPLETED

Trial details

NCT number
NCT04853992
Sponsor
JW Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cholinergic Urticaria
Start date
2021-05-10
Primary completion
2022-07-08
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.